Represented China Cord Blood Corp. (NYSE: CO) in a $50 million private equity investment by Golden Meditech Holdings Ltd., a significant shareholder of the company. We provided counsel in connection with the issuance of convertible debt, the receipt of NYSE listing approval and related issues, and filings with the Securities and Exchange Commission.
-
副主席兼纽约办公室管理合伙人;资本市场及公司业务部联席主席;亚洲业务部主席”; 纽约,北京
-
合伙人